10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

ABBOTT LABORATORIES

Ticker: ABT   Fiscal Year: 2011

Consolidated Balance Sheet

Period Ending Dec 31, 2011 10-K (Filed: Feb 21, 2012)

(In Thousands, except shares in actual)
 As ofAs of
 Dec 31, 2011Dec 31, 2010
Current Assets:
Cash and cash equivalents
$
6,812,820
3,648,371
Investments, primarily time deposits and certificates of deposit1,284,5391,803,079
Restricted funds, primarily U.S. treasury bills1,872,490
Trade receivables, less allowances of - 2011: $420,579; 2010: $388,564; 2009: $311,5467,683,9207,184,034
Inventories:
Finished products2,220,5272,058,735
Work in process432,358383,580
Materials631,364746,419
Total inventories3,284,2493,188,734
 
Deferred income taxes2,700,5403,076,051
Other prepaid expenses and receivables2,002,7061,544,770
Total Current Assets23,768,77422,317,529
 
Investments378,225302,049
Property and Equipment, at Cost:
Land633,917648,988
Buildings4,467,3874,334,236
Equipment12,216,38811,813,618
Construction in progress698,873577,460
Property and Equipment, at Cost18,016,56517,374,302
 
Less: accumulated depreciation and amortization10,142,6109,403,346
Net Property and Equipment7,873,9557,970,956
 
Intangible Assets, net of amortization9,989,63612,151,628
Goodwill15,705,38015,930,077
Deferred Income Taxes and Other Assets2,560,9231,901,613
Total Assets60,276,89360,573,852
 
Liabilities and Shareholders' Investment
Current Liabilities:
Short-term borrowings2,347,8594,349,796
Trade accounts payable1,721,1271,535,759
Salaries, wages and commissions1,260,1211,328,665
Other accrued liabilities7,854,9946,014,772
Dividends payable754,284680,749
Income taxes payable514,9471,307,723
Current portion of long-term debt1,026,8962,044,970
Total Current Liabilities15,480,22817,262,434
 
Long-term Debt12,039,82212,523,517
Post-employment Obligations and Other Long-term Liabilities8,230,6988,022,770
Commitments and Contingencies  
Shareholders' Investment:
Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued  
Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2011: 1,638,870,201; 2010: 1,619,689,876; 2009: 1,612,683,9879,817,1348,744,703
Common shares held in treasury, at cost - Shares: 2011: 68,491,382; 2010: 72,705,928; 2009: 61,516,398(3,687,478)(3,916,823)
Earnings employed in the business20,907,36219,215,768
Accumulated other comprehensive income (loss)(2,597,185)(1,366,846)
Total Abbott Shareholders' Investment24,439,83322,676,802
 
Noncontrolling Interests in Subsidiaries86,31288,329
Total Shareholders' Investment24,526,14522,765,131
 
Total Liabilities and Shareholders' Investment60,276,89360,573,852
 
External Links 
ABBOTT LABORATORIES (ABT) Fiscal Year 2011
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip